A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00097019
Recruitment Status : Completed
First Posted : November 18, 2004
Last Update Posted : May 16, 2017
Information provided by (Responsible Party):
Genentech, Inc.